Papaloisou launches Emconcor tablets
Date: 30 Jun 2016

Emconcor® (bisoprolol) is a selective β1-blocker approved for treatment of stable chronic heart failure with reduced systolic left ventricular function. Emconcor is produced by MERCK of Germany.

For more information about Emconcor please click here.